Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

July 30, 2020

Animal models of high-risk corneal transplantation: A comprehensive review

Experimental Eye Research
Rohan Bir SinghReza Dana
July 3, 2020

Long-term topical bevacizumab for prevention of corneal graft rejections

European Journal of Ophthalmology
Hua-Hsuan Kuo, Elizabeth P Shen
July 18, 2020
Comment / Editorial
Open Access

More Studies are Needed Evaluating the Diagnostic Accuracy of Magnetic Resonance Elastography for Allograft Renal Transplant Rejection

Korean Journal of Radiology : Official Journal of the Korean Radiological Society
Mitchell P WilsonGavin Low
July 1, 2020
Open Access

Using Artificial Intelligence Resources in Dialysis and Kidney Transplant Patients: A Literature Review

BioMed Research International
Alexandru BurlacuAdrian Covic
July 31, 2020
Open Access

Prognosis of heart transplant patients in Mashhad University of Medical Sciences

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery
Mohammad Abbasi TeshnisiAbbas Ardehali
July 1, 2020
Open Access

Lymph node fibroblastic reticular cells deposit fibrosis-associated collagen following organ transplantation

The Journal of Clinical Investigation
Xiaofei LiReza Abdi
August 2, 2020

Parafoveal atrophy after human amniotic membrane graft for macular hole in patients with high myopia

The British Journal of Ophthalmology
Der-Chong TsaiShih-Jen Chen
August 5, 2020

Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors

European Journal of Haematology
Jean-Sébastien ClaveauJean Roy
July 1, 2020

Type 3 innate lymphoid cells are associated with a successful intestinal transplant

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jiman KangAlexander Kroemer
July 3, 2020

Development and validation of a combined enzymatic-digestion/mass spectrometry assay for Tacrolimus quantitation in cardiac biopsies

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Mariadelfina MolinaroSimona De Gregori
July 12, 2020
Open Access

Outcome of peripheral blood allogeneic hematopoietic stem cell transplantation as a treatment option in patients with severe aplastic anemia between 40 and 50 years

Hematology/oncology and Stem Cell Therapy
Hosein Kamranzadeh FumaniArdeshir Ghavamzadeh
July 7, 2020
Open Access

The utility of DLA typing for transplantation medicine in canine models

The Journal of Veterinary Medical Science
Keita SatoTadaaki Moritomo

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2020 Meta ULC. All rights reserved